APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-vertigo Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-vertigo Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchAnti-vertigo Drugs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-vertigo Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Anti-vertigo Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-vertigo Drugs Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-vertigo Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Anti-vertigo Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-vertigo Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-vertigo Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-vertigo Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-vertigo Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-vertigo Drugs include Zhejiang Proconyu Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Weifang Zhongshi Pharmaceutical Co., Ltd., Tianfang Pharmaceutical Co., Ltd., Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd., Shanghai SPH Xinyi Pharmaceutical Co., Ltd., Shandong Xinyi Pharmaceutical Co., Ltd., Renhetang Pharmaceutical Co., Ltd. and Jiangsu Sihuan Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-vertigo Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-vertigo Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-vertigo Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-vertigo Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-vertigo Drugs Segment by Company

Zhejiang Proconyu Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Weifang Zhongshi Pharmaceutical Co., Ltd.

Tianfang Pharmaceutical Co., Ltd.

Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Shandong Xinyi Pharmaceutical Co., Ltd.

Renhetang Pharmaceutical Co., Ltd.

Jiangsu Sihuan Biopharmaceutical Co., Ltd.

Jinan Yongning Pharmaceutical Co., Ltd.

China Resources Shuanghe Pharmaceutical Co., Ltd.

Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.

Heilongjiang Yidahong Pharmaceutical Co., Ltd.

Henan Zhongjie Pharmaceutical Co., Ltd.

Guangdong Lingnan Pharmaceutical Co., Ltd.

Guangdong Bangmin Pharmaceutical Co., Ltd.

Beijing Juneng Pharmaceutical Co., Ltd.

Wellona Pharma

SAVAL Pharma

Santa Cruz Biotechnology, Inc

Kent Pharmaceuticals Ltd

Kabir Lifesciences

AdvaCare Pharma

Anti-vertigo Drugs Segment by Type

Betahistine

Diphenidol

Flunarizine

Anti-vertigo Drugs Segment by Application

Clinic

Hospital

Pharmacy

Other

Anti-vertigo Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-vertigo Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-vertigo Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-vertigo Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-vertigo Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-vertigo Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-vertigo Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-vertigo Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-vertigo Drugs Industry Trends Table 2. Anti-vertigo Drugs Industry Drivers Table 3. Anti-vertigo Drugs Industry Opportunities and Challenges Table 4. Anti-vertigo Drugs Industry Restraints Table 5. Global Anti-vertigo Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-vertigo Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-vertigo Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Anti-vertigo Drugs Sales Market Share by Manufacturers Table 9. Global Anti-vertigo Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Anti-vertigo Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-vertigo Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-vertigo Drugs Manufacturers, Product Type & Application Table 13. Global Anti-vertigo Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-vertigo Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Betahistine Table 17. Major Manufacturers of Diphenidol Table 18. Major Manufacturers of Flunarizine Table 19. Global Anti-vertigo Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Anti-vertigo Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Anti-vertigo Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Anti-vertigo Drugs Sales Market Share by Type (2021-2026) Table 23. Global Anti-vertigo Drugs Sales Market Share by Type (2027-2032) Table 24. Global Anti-vertigo Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Anti-vertigo Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Anti-vertigo Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Anti-vertigo Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Anti-vertigo Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Pharmacy Table 32. Major Manufacturers of Other Table 33. Global Anti-vertigo Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Anti-vertigo Drugs Sales by Application (2021-2026) & (K Units) Table 35. Global Anti-vertigo Drugs Sales by Application (2027-2032) & (K Units) Table 36. Global Anti-vertigo Drugs Sales Market Share by Application (2021-2026) Table 37. Global Anti-vertigo Drugs Sales Market Share by Application (2027-2032) Table 38. Global Anti-vertigo Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Anti-vertigo Drugs Revenue by Application (2021-2026) & (K Units) Table 40. Global Anti-vertigo Drugs Revenue by Application (2027-2032) & (K Units) Table 41. Global Anti-vertigo Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Anti-vertigo Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Anti-vertigo Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Anti-vertigo Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Anti-vertigo Drugs Sales Market Share by Region (2021-2026) Table 46. Global Anti-vertigo Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Anti-vertigo Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Anti-vertigo Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 50. North America Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units) Table 51. Europe Anti-vertigo Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 53. Europe Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Anti-vertigo Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Anti-vertigo Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Anti-vertigo Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Anti-vertigo Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Anti-vertigo Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Anti-vertigo Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Anti-vertigo Drugs Revenue Market Share by Region (2027-2032) Table 65. Zhejiang Proconyu Pharmaceutical Co., Ltd. Company Information Table 66. Zhejiang Proconyu Pharmaceutical Co., Ltd. Business Overview Table 67. Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 69. Zhejiang Proconyu Pharmaceutical Co., Ltd. Recent Development Table 70. Southwest Pharmaceutical Co., Ltd. Company Information Table 71. Southwest Pharmaceutical Co., Ltd. Business Overview Table 72. Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 74. Southwest Pharmaceutical Co., Ltd. Recent Development Table 75. Weifang Zhongshi Pharmaceutical Co., Ltd. Company Information Table 76. Weifang Zhongshi Pharmaceutical Co., Ltd. Business Overview Table 77. Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 79. Weifang Zhongshi Pharmaceutical Co., Ltd. Recent Development Table 80. Tianfang Pharmaceutical Co., Ltd. Company Information Table 81. Tianfang Pharmaceutical Co., Ltd. Business Overview Table 82. Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 84. Tianfang Pharmaceutical Co., Ltd. Recent Development Table 85. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Company Information Table 86. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Business Overview Table 87. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 89. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Recent Development Table 90. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information Table 91. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview Table 92. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 94. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Development Table 95. Shandong Xinyi Pharmaceutical Co., Ltd. Company Information Table 96. Shandong Xinyi Pharmaceutical Co., Ltd. Business Overview Table 97. Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 99. Shandong Xinyi Pharmaceutical Co., Ltd. Recent Development Table 100. Renhetang Pharmaceutical Co., Ltd. Company Information Table 101. Renhetang Pharmaceutical Co., Ltd. Business Overview Table 102. Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 104. Renhetang Pharmaceutical Co., Ltd. Recent Development Table 105. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Company Information Table 106. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Business Overview Table 107. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 109. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Recent Development Table 110. Jinan Yongning Pharmaceutical Co., Ltd. Company Information Table 111. Jinan Yongning Pharmaceutical Co., Ltd. Business Overview Table 112. Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 114. Jinan Yongning Pharmaceutical Co., Ltd. Recent Development Table 115. China Resources Shuanghe Pharmaceutical Co., Ltd. Company Information Table 116. China Resources Shuanghe Pharmaceutical Co., Ltd. Business Overview Table 117. China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 119. China Resources Shuanghe Pharmaceutical Co., Ltd. Recent Development Table 120. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information Table 121. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Development Table 125. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Company Information Table 126. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Business Overview Table 127. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 129. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Recent Development Table 130. Henan Zhongjie Pharmaceutical Co., Ltd. Company Information Table 131. Henan Zhongjie Pharmaceutical Co., Ltd. Business Overview Table 132. Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 134. Henan Zhongjie Pharmaceutical Co., Ltd. Recent Development Table 135. Guangdong Lingnan Pharmaceutical Co., Ltd. Company Information Table 136. Guangdong Lingnan Pharmaceutical Co., Ltd. Business Overview Table 137. Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 139. Guangdong Lingnan Pharmaceutical Co., Ltd. Recent Development Table 140. Guangdong Bangmin Pharmaceutical Co., Ltd. Company Information Table 141. Guangdong Bangmin Pharmaceutical Co., Ltd. Business Overview Table 142. Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 144. Guangdong Bangmin Pharmaceutical Co., Ltd. Recent Development Table 145. Beijing Juneng Pharmaceutical Co., Ltd. Company Information Table 146. Beijing Juneng Pharmaceutical Co., Ltd. Business Overview Table 147. Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 149. Beijing Juneng Pharmaceutical Co., Ltd. Recent Development Table 150. Wellona Pharma Company Information Table 151. Wellona Pharma Business Overview Table 152. Wellona Pharma Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Wellona Pharma Anti-vertigo Drugs Product Portfolio Table 154. Wellona Pharma Recent Development Table 155. SAVAL Pharma Company Information Table 156. SAVAL Pharma Business Overview Table 157. SAVAL Pharma Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. SAVAL Pharma Anti-vertigo Drugs Product Portfolio Table 159. SAVAL Pharma Recent Development Table 160. Santa Cruz Biotechnology, Inc Company Information Table 161. Santa Cruz Biotechnology, Inc Business Overview Table 162. Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Product Portfolio Table 164. Santa Cruz Biotechnology, Inc Recent Development Table 165. Kent Pharmaceuticals Ltd Company Information Table 166. Kent Pharmaceuticals Ltd Business Overview Table 167. Kent Pharmaceuticals Ltd Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Kent Pharmaceuticals Ltd Anti-vertigo Drugs Product Portfolio Table 169. Kent Pharmaceuticals Ltd Recent Development Table 170. Kabir Lifesciences Company Information Table 171. Kabir Lifesciences Business Overview Table 172. Kabir Lifesciences Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Kabir Lifesciences Anti-vertigo Drugs Product Portfolio Table 174. Kabir Lifesciences Recent Development Table 175. AdvaCare Pharma Company Information Table 176. AdvaCare Pharma Business Overview Table 177. AdvaCare Pharma Anti-vertigo Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. AdvaCare Pharma Anti-vertigo Drugs Product Portfolio Table 179. AdvaCare Pharma Recent Development Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Anti-vertigo Drugs Distributors List Table 183. Anti-vertigo Drugs Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Anti-vertigo Drugs Product Image Figure 2. Global Anti-vertigo Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-vertigo Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-vertigo Drugs Sales (2021-2032) & (K Units) Figure 5. Global Anti-vertigo Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-vertigo Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Betahistine Image Figure 9. Diphenidol Image Figure 10. Flunarizine Image Figure 11. Global Anti-vertigo Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Anti-vertigo Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Anti-vertigo Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Anti-vertigo Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Anti-vertigo Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Anti-vertigo Drugs Revenue Market Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Other Image Figure 21. Global Anti-vertigo Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Anti-vertigo Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Anti-vertigo Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Anti-vertigo Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Anti-vertigo Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Anti-vertigo Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Anti-vertigo Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Anti-vertigo Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Anti-vertigo Drugs Sales Market Share by Country (2021-2032) Figure 41. China Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Anti-vertigo Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Anti-vertigo Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Anti-vertigo Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Anti-vertigo Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Anti-vertigo Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Anti-vertigo Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Anti-vertigo Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Anti-vertigo Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Anti-vertigo Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Anti-vertigo Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Anti-vertigo Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Anti-vertigo Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anti-vertigo Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Anti-vertigo Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Betahistine
  • Diphenidol
  • Flunarizine
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Zhejiang Proconyu Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Weifang Zhongshi Pharmaceutical Co., Ltd.
  • Tianfang Pharmaceutical Co., Ltd.
  • Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
  • Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  • Shandong Xinyi Pharmaceutical Co., Ltd.
  • Renhetang Pharmaceutical Co., Ltd.
  • Jiangsu Sihuan Biopharmaceutical Co., Ltd.
  • Jinan Yongning Pharmaceutical Co., Ltd.
  • China Resources Shuanghe Pharmaceutical Co., Ltd.
  • Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
  • Heilongjiang Yidahong Pharmaceutical Co., Ltd.
  • Henan Zhongjie Pharmaceutical Co., Ltd.
  • Guangdong Lingnan Pharmaceutical Co., Ltd.
  • Guangdong Bangmin Pharmaceutical Co., Ltd.
  • Beijing Juneng Pharmaceutical Co., Ltd.
  • Wellona Pharma
  • SAVAL Pharma
  • Santa Cruz Biotechnology, Inc
  • Kent Pharmaceuticals Ltd
  • Kabir Lifesciences
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-vertigo Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-vertigo Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-vertigo Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-vertigo Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-vertigo Drugs Market Dynamics
  1. 2.1 Anti-vertigo Drugs Industry Trends
  2. 2.2 Anti-vertigo Drugs Industry Drivers
  3. 2.3 Anti-vertigo Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-vertigo Drugs Industry Restraints
3 Anti-vertigo Drugs Market by Manufacturers
  1. 3.1 Global Anti-vertigo Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-vertigo Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-vertigo Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-vertigo Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-vertigo Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-vertigo Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Anti-vertigo Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-vertigo Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-vertigo Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-vertigo Drugs Tier 1, Tier 2, and Tier 3
4 Anti-vertigo Drugs Market by Type
  1. 4.1 Anti-vertigo Drugs Type Introduction
  2. 4.1.1 Betahistine
  3. 4.1.2 Diphenidol
  4. 4.1.3 Flunarizine
  5. 4.2 Global Anti-vertigo Drugs Sales by Type
  6. 4.2.1 Global Anti-vertigo Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Anti-vertigo Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Anti-vertigo Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Anti-vertigo Drugs Revenue by Type
  10. 4.3.1 Global Anti-vertigo Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Anti-vertigo Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Anti-vertigo Drugs Revenue Market Share by Type (2021-2032)
5 Anti-vertigo Drugs Market by Application
  1. 5.1 Anti-vertigo Drugs Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Other
  6. 5.2 Global Anti-vertigo Drugs Sales by Application
  7. 5.2.1 Global Anti-vertigo Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-vertigo Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Anti-vertigo Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Anti-vertigo Drugs Revenue by Application
  11. 5.3.1 Global Anti-vertigo Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Anti-vertigo Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Anti-vertigo Drugs Revenue Market Share by Application (2021-2032)
6 Global Anti-vertigo Drugs Sales by Region
  1. 6.1 Global Anti-vertigo Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-vertigo Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-vertigo Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-vertigo Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-vertigo Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-vertigo Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-vertigo Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-vertigo Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-vertigo Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-vertigo Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-vertigo Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-vertigo Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-vertigo Drugs Revenue by Region
  1. 7.1 Global Anti-vertigo Drugs Revenue by Region
  2. 7.1.1 Global Anti-vertigo Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-vertigo Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-vertigo Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-vertigo Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-vertigo Drugs Revenue (2021-2032)
  8. 7.2.2 North America Anti-vertigo Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-vertigo Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Anti-vertigo Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-vertigo Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-vertigo Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-vertigo Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-vertigo Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Proconyu Pharmaceutical Co., Ltd.
  2. 8.1.1 Zhejiang Proconyu Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Zhejiang Proconyu Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  6. 8.1.5 Zhejiang Proconyu Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Southwest Pharmaceutical Co., Ltd.
  8. 8.2.1 Southwest Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  12. 8.2.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Weifang Zhongshi Pharmaceutical Co., Ltd.
  14. 8.3.1 Weifang Zhongshi Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Weifang Zhongshi Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  18. 8.3.5 Weifang Zhongshi Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Tianfang Pharmaceutical Co., Ltd.
  20. 8.4.1 Tianfang Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Tianfang Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  24. 8.4.5 Tianfang Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
  26. 8.5.1 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  30. 8.5.5 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  32. 8.6.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  36. 8.6.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shandong Xinyi Pharmaceutical Co., Ltd.
  38. 8.7.1 Shandong Xinyi Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shandong Xinyi Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  42. 8.7.5 Shandong Xinyi Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Renhetang Pharmaceutical Co., Ltd.
  44. 8.8.1 Renhetang Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Renhetang Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  48. 8.8.5 Renhetang Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jiangsu Sihuan Biopharmaceutical Co., Ltd.
  50. 8.9.1 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  54. 8.9.5 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Jinan Yongning Pharmaceutical Co., Ltd.
  56. 8.10.1 Jinan Yongning Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Jinan Yongning Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  60. 8.10.5 Jinan Yongning Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 China Resources Shuanghe Pharmaceutical Co., Ltd.
  62. 8.11.1 China Resources Shuanghe Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 China Resources Shuanghe Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  66. 8.11.5 China Resources Shuanghe Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
  68. 8.12.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  72. 8.12.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Heilongjiang Yidahong Pharmaceutical Co., Ltd.
  74. 8.13.1 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  78. 8.13.5 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Henan Zhongjie Pharmaceutical Co., Ltd.
  80. 8.14.1 Henan Zhongjie Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Henan Zhongjie Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  84. 8.14.5 Henan Zhongjie Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Guangdong Lingnan Pharmaceutical Co., Ltd.
  86. 8.15.1 Guangdong Lingnan Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Guangdong Lingnan Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  90. 8.15.5 Guangdong Lingnan Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Guangdong Bangmin Pharmaceutical Co., Ltd.
  92. 8.16.1 Guangdong Bangmin Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Guangdong Bangmin Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  96. 8.16.5 Guangdong Bangmin Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Beijing Juneng Pharmaceutical Co., Ltd.
  98. 8.17.1 Beijing Juneng Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Beijing Juneng Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  102. 8.17.5 Beijing Juneng Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Wellona Pharma
  104. 8.18.1 Wellona Pharma Company Information
  105. 8.18.2 Wellona Pharma Business Overview
  106. 8.18.3 Wellona Pharma Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Wellona Pharma Anti-vertigo Drugs Product Portfolio
  108. 8.18.5 Wellona Pharma Recent Developments
  109. 8.19 SAVAL Pharma
  110. 8.19.1 SAVAL Pharma Company Information
  111. 8.19.2 SAVAL Pharma Business Overview
  112. 8.19.3 SAVAL Pharma Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 SAVAL Pharma Anti-vertigo Drugs Product Portfolio
  114. 8.19.5 SAVAL Pharma Recent Developments
  115. 8.20 Santa Cruz Biotechnology, Inc
  116. 8.20.1 Santa Cruz Biotechnology, Inc Company Information
  117. 8.20.2 Santa Cruz Biotechnology, Inc Business Overview
  118. 8.20.3 Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Product Portfolio
  120. 8.20.5 Santa Cruz Biotechnology, Inc Recent Developments
  121. 8.21 Kent Pharmaceuticals Ltd
  122. 8.21.1 Kent Pharmaceuticals Ltd Company Information
  123. 8.21.2 Kent Pharmaceuticals Ltd Business Overview
  124. 8.21.3 Kent Pharmaceuticals Ltd Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Kent Pharmaceuticals Ltd Anti-vertigo Drugs Product Portfolio
  126. 8.21.5 Kent Pharmaceuticals Ltd Recent Developments
  127. 8.22 Kabir Lifesciences
  128. 8.22.1 Kabir Lifesciences Company Information
  129. 8.22.2 Kabir Lifesciences Business Overview
  130. 8.22.3 Kabir Lifesciences Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Kabir Lifesciences Anti-vertigo Drugs Product Portfolio
  132. 8.22.5 Kabir Lifesciences Recent Developments
  133. 8.23 AdvaCare Pharma
  134. 8.23.1 AdvaCare Pharma Company Information
  135. 8.23.2 AdvaCare Pharma Business Overview
  136. 8.23.3 AdvaCare Pharma Anti-vertigo Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 AdvaCare Pharma Anti-vertigo Drugs Product Portfolio
  138. 8.23.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-vertigo Drugs Value Chain Analysis
  2. 9.1.1 Anti-vertigo Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-vertigo Drugs Production Mode & Process
  6. 9.2 Anti-vertigo Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-vertigo Drugs Distributors
  9. 9.2.3 Anti-vertigo Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst